Literature DB >> 19758648

Gastric bypass procedures and renal calculi--how should we counsel patients and bariatric surgeons?

John C Lieske.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19758648      PMCID： PMC3899890          DOI： 10.1016/j.juro.2009.08.079

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  9 in total

1.  Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.

Authors:  John R Asplin; Fredric L Coe
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

Review 2.  Bariatric surgery: a review of procedures and outcomes.

Authors:  Katherine A Elder; Bruce M Wolfe
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

3.  Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery.

Authors:  M K Sinha; M L Collazo-Clavell; A Rule; D S Milliner; W Nelson; M G Sarr; R Kumar; J C Lieske
Journal:  Kidney Int       Date:  2007-03-21       Impact factor: 10.612

Review 4.  Surgical options for obesity.

Authors:  Eric J Demaria; Mohammad K Jamal
Journal:  Gastroenterol Clin North Am       Date:  2005-03       Impact factor: 3.806

5.  Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.

Authors:  Wayne K Nelson; Scott G Houghton; Dawn S Milliner; John C Lieske; Michael G Sarr
Journal:  Surg Obes Relat Dis       Date:  2005-08-26       Impact factor: 4.734

6.  Effect of gastric bypass surgery on kidney stone disease.

Authors:  Brian R Matlaga; Andrew D Shore; Thomas Magnuson; Jeanne M Clark; Roger Johns; Martin A Makary
Journal:  J Urol       Date:  2009-04-16       Impact factor: 7.450

7.  Perioperative safety in the longitudinal assessment of bariatric surgery.

Authors:  David Reed Flum; Steven H Belle; Wendy C King; Abdus S Wahed; Paul Berk; William Chapman; Walter Pories; Anita Courcoulas; Carol McCloskey; James Mitchell; Emma Patterson; Alfons Pomp; Myrlene A Staten; Susan Z Yanovski; Richard Thirlby; Bruce Wolfe
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

8.  Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal.

Authors:  J A Requarth; K W Burchard; T A Colacchio; T A Stukel; L A Mott; E R Greenberg; R E Weismann
Journal:  Arch Surg       Date:  1995-03

9.  Effects of bariatric surgery on mortality in Swedish obese subjects.

Authors:  Lars Sjöström; Kristina Narbro; C David Sjöström; Kristjan Karason; Bo Larsson; Hans Wedel; Ted Lystig; Marianne Sullivan; Claude Bouchard; Björn Carlsson; Calle Bengtsson; Sven Dahlgren; Anders Gummesson; Peter Jacobson; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Ingmar Näslund; Torsten Olbers; Kaj Stenlöf; Jarl Torgerson; Göran Agren; Lena M S Carlsson
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245
  9 in total
  4 in total

Review 1.  [Benign prostatic hyperplasia and urolithiasis].

Authors:  P Krombach; M S Michel
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

2.  Prospective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.

Authors:  W Robert DeFoor; John R Asplin; Linda Kollar; Elizabeth Jackson; Todd Jenkins; Marion Schulte; Thomas Inge
Journal:  Surg Obes Relat Dis       Date:  2015-03-28       Impact factor: 4.734

3.  Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.

Authors:  Rajiv Kumar; John C Lieske; Maria L Collazo-Clavell; Michael G Sarr; Ellen R Olson; Terri J Vrtiska; Eric J Bergstralh; Xujian Li
Journal:  Surgery       Date:  2011-02-05       Impact factor: 3.982

4.  Prospective evaluation of urinary incontinence in severely obese adolescents presenting for weight loss surgery.

Authors:  W Robert DeFoor; Thomas H Inge; Todd M Jenkins; Elizabeth Jackson; Anita Courcoulas; Marc Michalsky; Mary Brandt; Linda Kollar; Changchun Xie
Journal:  Surg Obes Relat Dis       Date:  2017-09-14       Impact factor: 4.734
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.